Caxton Associates (New York)’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-167,957
| Closed | -$588K | – | 551 |
|
|
2024
Q3 | $588K | Sell |
167,957
-4,906
| -3% | -$17.2K | 0.02% | 339 |
|
|
2024
Q2 | $567K | Sell |
172,863
-117,324
| -40% | -$385K | 0.02% | 325 |
|
|
2024
Q1 | $2.13M | Buy |
+290,187
| New | +$2.13M | 0.12% | 111 |
|
|
2023
Q3 | – | Sell |
-40,719
| Closed | -$194K | – | 472 |
|
|
2023
Q2 | $194K | Sell |
40,719
-43,633
| -52% | -$208K | 0.03% | 418 |
|
|
2023
Q1 | $481K | Buy |
+84,352
| New | +$481K | 0.07% | 267 |
|